BenzingaOctober 15, 2026 at 12:27 PM NY12 Days Ago
MiniMed Names Kevin E. Lofton Board Chair, Effective Separation From Medtronic
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the composition of its Board of Directors following the completion of the company's separation from Medtronic. This new Board
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
